Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseasesRamya Ramaswami, Robert Yarchoan, Adam Rupert et al.|Blood Advances|2021Cited by 78
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphomaKathryn Lurain, Robert Yarchoan, Ramya Ramaswami et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 69
Characteristics and outcomes of Kaposi sarcoma herpesvirus–associated inflammatory cytokine syndromeRamya Ramaswami, Robert Yarchoan, Kathryn Lurain et al.|Blood Advances|2025Cited by 12
Phase I Study of Lenalidomide Combined with Dose-Adjusted EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma in Participants with or without HIV (NCT02911142)Kathryn Lurain, Robert Yarchoan, Ramya Ramaswami et al.|Blood|2020Cited by 5